Discover AQST's growth potential with Anaphylm's FDA approval by Q2'25 targeting $1B revenue. Learn DCF valuations offering ...

Retrograde alopecia is a form of hair loss characterized by the gradual thinning or recession of hair at the nape of the neck ...

Experiencing an itchy scalp isn’t just frustrating, it’s also such an uncomfortable feeling. If you’ve ever had an itchy ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Bald spots can feel like a punch to your confidence - sudden, unexplained patches of missing hair are never welcome surprises ...

If you recognise any of the symptoms, consult a medical professional to check if they indicate any underlying medical ...

Experiencing hair fall is common, but excessive shedding signals underlying issues. Sudden hair loss, thinning, or bald spots ...

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...

Medically reviewed by Susan Bard, MD Alopecia areata is a common hair loss condition. It affects people of all ages, races, ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...